HHSN272201800009I advanced bioscience laboratories, INC process development for panfungal vaccine base award can 8470036 for $159,189.00 can 8470038 for $318,377.00 total $477,566.00
Ended Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $639,462
Award facts
- Contract value 57% obligated
-
- $639,462.08 Current, with exercised options
- $1,124,664.08 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $28,455 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $133,441 | |
| Original award | $477,566 |
About this award
This is a $1,124,664.08 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a large for-profit manufacturer. The contract is for process development services to support the creation of a panfungal vaccine. This work was originally awarded under contract HHSN272201800009I, and this order, 75N93023F00001, is a continuation of that effort. The contract does not have a set-aside designation. ABL is a leading contract research and manufacturing organization specializing in the development of vaccines, therapeutics, and other biologics. The company has extensive experience supporting federal agencies like NIAID and the National Cancer Institute through R&D and production contracts and grants.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 20, 2023.
How much is contract 75N93023F00001 worth?
The government has obligated $639,462 on 75N93023F00001. Its potential value, with all options, is $1,124,664.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under 75N93018D00009, an indefinite delivery contract.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award